BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 21920438)

  • 1. Brain aging, Alzheimer's disease, and mitochondria.
    Swerdlow RH
    Biochim Biophys Acta; 2011 Dec; 1812(12):1630-9. PubMed ID: 21920438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial links between brain aging and Alzheimer's disease.
    Wilkins HM; Swerdlow RH
    Transl Neurodegener; 2021 Sep; 10(1):33. PubMed ID: 34465385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β.
    Huang Z; Yan Q; Wang Y; Zou Q; Li J; Liu Z; Cai Z
    J Alzheimers Dis; 2020; 78(2):505-514. PubMed ID: 33044180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease.
    Orsucci D; Mancuso M; Ienco EC; Simoncini C; Siciliano G; Bonuccelli U
    Curr Neurovasc Res; 2013 Feb; 10(1):76-80. PubMed ID: 23151073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?
    Mecocci P; Baroni M; Senin U; Boccardi V
    J Alzheimers Dis; 2018; 64(s1):S397-S404. PubMed ID: 29562513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.
    Galvan V; Hart MJ
    Biochim Biophys Acta; 2016 May; 1862(5):992-1007. PubMed ID: 26639036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Alzheimer's disease.
    Swerdlow RH
    Clin Interv Aging; 2007; 2(3):347-59. PubMed ID: 18044185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease.
    Kim DK; Mook-Jung I
    BMB Rep; 2019 Dec; 52(12):679-688. PubMed ID: 31722781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.
    Reddy PH; Manczak M; Mao P; Calkins MJ; Reddy AP; Shirendeb U
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S499-512. PubMed ID: 20413847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding risk factors for Alzheimer's disease: interplay of neuroinflammation, connexin-based communication and oxidative stress.
    Quintanilla RA; Orellana JA; von Bernhardi R
    Arch Med Res; 2012 Nov; 43(8):632-44. PubMed ID: 23142264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer's disease.
    Atamna H
    J Alzheimers Dis; 2006 Nov; 10(2-3):255-66. PubMed ID: 17119291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Alzheimer's disease mitochondrial cascade hypothesis.
    Swerdlow RH; Burns JM; Khan SM
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S265-79. PubMed ID: 20442494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocytes in the Peripheral Clearance of Amyloid-β and Alzheimer's Disease.
    Guo H; Zhao Z; Zhang R; Chen P; Zhang X; Cheng F; Gou X
    J Alzheimers Dis; 2019; 68(4):1391-1400. PubMed ID: 30958361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View.
    Penke B; Bogár F; Fülöp L
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28994715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
    Heininger K
    Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease.
    Palacios HH; Yendluri BB; Parvathaneni K; Shadlinski VB; Obrenovich ME; Leszek J; Gokhman D; Gąsiorowski K; Bragin V; Aliev G
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):149-62. PubMed ID: 21222631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial translocation of amyloid precursor protein and its cleaved products: relevance to mitochondrial dysfunction in Alzheimer's disease.
    Anandatheerthavarada HK; Devi L
    Rev Neurosci; 2007; 18(5):343-54. PubMed ID: 19544621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid Β-Peptide Increases Mitochondria-Endoplasmic Reticulum Contact Altering Mitochondrial Function and Autophagosome Formation in Alzheimer's Disease-Related Models.
    Leal NS; Dentoni G; Schreiner B; Naia L; Piras A; Graff C; Cattaneo A; Meli G; Hamasaki M; Nilsson P; Ankarcrona M
    Cells; 2020 Nov; 9(12):. PubMed ID: 33260715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.